“Use of electromagnetic fields can suppress atrial fibrillation.”

News Releases

Pico-Tesla cites in vivo study at the University of Oklahoma Health Sciences Center that suggests low-level electromagnetic fields (EMFs) can prevent and reverse involuntary remodeling of the heart caused by atrial fibrillation (A-Fib)

Please Download the latest version of Adobe Flash Player.

ABOUT US

Our Team

Participate in our research
News Releases

Terms & Conditions of Use

FOR IMMEDIATE RELEASE
Contact: Ronald Trahan, APR, Ronald Trahan Associates Inc.
508-359-4005, x108

Study to be submitted for publication confirms earlier study (“Magnetism and Cardiac Arrhythmias) published in Cardiology in Review

“Use of electromagnetic fields can suppress atrial fibrillation.” Benjamin J. Scherlag, Ph.D., professor of medicine, Heart Rhythm Institute, Univ. of Oklahoma Health Sciences Center

LITTLETON, Colo., May 24, 2010 — Pico-Tesla, The Magneceutical™ Company, today cited data from an in vivo study recently completed at the Univ. of Oklahoma’s Heart Rhythm Institute that suggests extremely low-level electromagnetic fields (EMFs) can prevent and reverse involuntary remodeling of the heart by terminating and preventing atrial fibrillation (A-Fib). The principal investigator for the study was Benjamin J. Scherlag, Ph.D., and Sunny S. Po, M.D., Ph.D. of the Heart Rhythm Institute, University of Oklahoma Health Sciences Center.

An earlier study at the Heart Rhythm Institute—“Magnetism and Cardiac Arrhythmias,” Cardiology in Review, March/April 2004)—also concluded that “…EMF…(is) effective in suppressing atrial fibrillation.”

“If this result can be replicated in a human study, then it may represent a non-invasive treatment option that would have significant benefits over the current treatment standards (e.g., drugs and/or cardio ablation procedures),” said Dr. Scherlag.

Pico-Tesla’s Magneceutical® Therapy involves the use of an extremely low-level electromagnetic field (EMF) applied by a specially designed device—the Resonator™, invented by Dr. Jerry I. Jacobson, along with proprietary therapeutic protocols—intended to improve a number of the signs and symptoms of major diseases. Pico-Tesla is currently sponsoring clinical trials for both Parkinson’s disease and type 2 diabetes.

“This is an exciting milestone, as it is a demonstration of a distinct biologic effect utilizing our technology and a major disease. Accordingly, we are in discussions with leading cardiology groups regarding the design and implementation of an exploratory study involving men and women with paroxsysmal A-Fib,” added Allen Braswell, CEO of Pico-Tesla.

Privately held Pico-Tesla Magnetic Therapies is an emerging medical technology company based in Clearwater, Florida.

CAUTION: The Resonator™ device is an Investigational Device limited by federal (or United States) law to investigational use. The Resonator™ device is not for sale, nor is the Magneceutical® Therapy generally available outside of Investigational Review Board (IRB)-approved clinical studies.

4700 140th Ave. N., Suite 101 • Clearwater, FL 33762 • 727-474-3722

HOME | CONTACT US

Website design by DDA Medical

The Resonator™ device is an Investigational Device limited by Federal (or United States)
law to investigational use. The Resonator™ device is not for sale, nor is the Magneceutical^®
Therapy generally available outside of Investigational Review Board (IRB) approved clinical studies.